Drug profile · INN
amikacin sulfate
ARIKAYCE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
amikacin sulfate (ARIKAYCE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN amikacin sulfate
Brand ARIKAYCE
Route INJECTION
Formulation SUSPENSION, LIPOSOMAL
ATC code J01GB06
Frequently asked questions
What is amikacin sulfate?
amikacin sulfate (ARIKAYCE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for amikacin sulfate?
ARIKAYCE is a marketed brand name for amikacin sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of amikacin sulfate?
amikacin sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.